Logo
x

Search

Subscribe Now

Zealand

Zealand Entered into a License and Development Agreement with Novo Nordisk for Zegalogue (dasiglucagon) to Treat Diabetes

Zealand Entered into a License and Development Agreement with Novo Nordisk for Zegalogue (dasiglucagon) to Treat Diabetes

  • September 7, 2022
Zealand Reports Results of Dasiglucagon in P-III (17103) Trial for the Treatment of Congenital Hyperinsulinism in Pediatric Patients

Zealand Reports Results of Dasiglucagon in P-III (17103) Trial for the Treatment of Congenital Hyperinsulinism in Pediatric Patien...

  • May 20, 2022
Insights+: The US FDA New Drug Approvals in March 2021

Insights+: The US FDA New Drug Approvals in March 2021

  • April 15, 2021
PharmaShots Weekly Snapshots (Mar 22 - 26, 2021)

PharmaShots Weekly Snapshots (Mar 22 - 26, 2021)

  • March 26, 2021
Top 20 Biopharma Deal Terminations of 2020 Based on Total Deal Value

Top 20 Biopharma Deal Terminations of 2020 Based on Total Deal Value

  • February 11, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.